Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Unlike resolvins E1 and E2, both of which are biosynthesised...
| Class:Id | Summation:9018884 |
|---|---|
| _displayName | Unlike resolvins E1 and E2, both of which are biosynthesised... |
| _timestamp | 2017-12-01 14:57:59 |
| created | [InstanceEdit:9018893] Jassal, Bijay, 2017-09-05 |
| modified | [InstanceEdit:9023654] Jassal, Bijay, 2017-09-28 [InstanceEdit:9031661] Jassal, Bijay, 2017-12-01 |
| text | Unlike resolvins E1 and E2, both of which are biosynthesised by neutrophils via the 5-lipoxygenase pathway, resolvin E3 (RvE3) is biosynthesised in eosinophils or resident macrophages via the 15-lipoxygenase (ALOX15) pathway. 18(R)-hydroxyeicosapentaenoic acid (18(R)-HEPE) is oxidised by ALOX15 (possibly through C13-hydrogen abstraction) into a number of dihydroxy-HEPEs including 17(R),18(R)-diHEPE (18(R)-RvE3) (Isobe et al. 2012, Isobe et al. 2013). |
| (summation) | [Reaction:9018907] ALOX15 oxidises 18(R)-HEPE to 18(R)-RvE3 [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Unlike resolvins E1 and E2, both of which are biosynthesised... (9018884)
